Welcome to the McGill International Tuberculosis Centre - A PAHO/WHO Collaborating Centre for Tuberculosis Research
It's time to End Drug-Resistant TB : The case for Action
Joint seminar IDIGH-TB Centre
Dr. Madhukar Pai will be giving a talk on May 22nd: The dark side of medical publishing: predators, pirates and profiteers.
Location: 1001, Boulevard Décarie, Bloc E, EM1.3509
Postdoctoral Fellowship in Tuberculosis & Private Provider Engagement - 2019-2020
The postdoctoral fellow will function as a junior investigator, participating fully in teaching, research and related scholarly activities and would be encouraged to apply for independent salary and research funding. Specifically, the fellow would contribute to research on Public-Private Mix and TB, private provider engagement, quality of TB care in the private health sector, and contribute to a learning network (i.e. community of practice) around private provider engagement and TB. Travel abroad will be required.
Important note: This is NOT a laboratory-based (bench science) fellowship.
Dick Menzies receives Distinguished Lecturer Award
Dr. Dick Menzies, Director of the Respiratory Epidemiology Unit at McGill and McGill’s World Health Organization Collaborating Centre in TB Research, has been named recipient of the 2019 CIHR-ICRH/CTS Distinguished Lecturer Award in Respiratory Sciences.
Each year, the Distinguished Lecturer Award (DLA) Series honours outstanding researchers within the Institute of Circulatory and Respiratory Health (ICRH) scientific research community who have contributed significantly to the advancement of science in their field of research both in Canada and internationally.
Dr. Marcel Behr received Tier 1 Canada Research Chair
Tier 1 Canada Research Chairs (CRC) are for outstanding researchers acknowledged by their peers as world leaders in their fields. A Chair is tenable for seven years and renewable once.
Chairholder title: Mycobacterial Genomics
Recent media appearances
For a world without tuberculosis
Building a tuberculosis-free world in The Lancet Commission on tuberculosis
We Have A New Roadmap To A World Without Tuberculosis in The Huffington Post
A human-rights approach is essential to end the global TB epidemic in The Conversation
Research Day 2019
Dr. Marcel Behr elected to Fellowship in the AAM
Dr. Marcel Behr has been elected to Fellowship in the American Academy of Microbiology. The Academy, the honorific leadership group within the American Society for Microbiology, recognizes excellence, originality, and leadership in the microbiological sciences, and his election to this group is a mark of distinction. Congratulations Dr. Behr!
Message from the Director:
With over 10 million new TB cases, and 1.6 million deaths, TB is the leading infectious killer of humanity. In Canada, the TB rate among the Inuit is about 283 times higher than that of the Canadian-born non-Indigenous. Thankfully, the world has committed to end the TB epidemic by 2030, and the Canadian government has pledged to end the TB epidemic in the Inuit Nunangat by 2030. The McGill International TB Centre is a world leader in the interdisciplinary study of TB. This Centre brings together more than 20 investigators with expertise in biomedical, clinical, epidemiologic and social aspects of TB. We work to better understand TB pathogenesis and host resistance, and also develop and evaluate new diagnostics, vaccines and treatment regimens for the control of TB. By means of quality training, technical assistance, capacity building, and policy-relevant research, our Centre aims to make a positive contribution to ending the TB epidemic nationally as well as globally.
December 3rd, 2018
Confronting a killer : New article about the McGill TB Centre written by Patrick McDonagh in McGill News
THE INTERNATIONAL COMMUNITY IS TURNING ITS ATTENTION TO THE MENACE OF TB AND A RESEARCH CENTRE AT MCGILL IS ALREADY PLAYING A MAJOR ROLE.
McGill International TB Centre designated as a PAHO/WHO Collaborating Center for Tuberculosis Research
more about Paho/WHO CC
Great job at knowledge synthesis by TB Centre researchers
Nature Review Primer on TB.
Just got designated as a ‘Highly cited paper’ by the Web of Science, meaning it is among the top 1% of papers of similar age in the field of clinical medicine! Read it here: http://go.nature.com/2Da2w2q
McGill authors topped the rankings as first and corresponding authors in systematic reviews and meta-analyses in TB research.
According to a study, McGill researchers account for 6% of the world's best cited TB papers which is very high ranking! The 100 top-cited tuberculosis research https://www.atsjournals.org/doi/10.1164/rccm.201707-1489PPstudies (International Union Against Tuberculosis and Lung Disease) Download
Positions in Tuberculosis Research Available:
Selected Recent TB Articles/Publications
Self-reported tuberculosis in India: evidence from NFHS-4. BMJ Global Health
Xpert MTB/RIF and Xpert MTB/RIF Ultra for pulmonary tuberculosis and rifampicin resistance in adults. Cochrane Database Syst Rev
What will it take to eliminate drug-resistant tuberculosis? Int J Tuberc Lung Dis